Arctic Bioscience AS (OSL:ABS) Other Current Receivables: kr8.16 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:ABS Arctic Bioscience AS OSL:ABS
51 GF Score
Price kr2.80
GF Value kr10.75
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS Other Current Receivables?

Arctic Bioscience AS OSL:ABS 51 Other Current Receivables is kr8.16 Mil as of Dec. 2025. GuruFocus rates OSL:ABS with a GF Score™ of 51/100 and a GF Value™ of kr10.75 (Possible Value Trap). The stock has 6 warning signs investors should review.

Arctic Bioscience AS's Other Current Receivables for the quarter that ended in Dec. 2025 was kr8.16 Mil.

Arctic Bioscience AS's quarterly Other Current Receivables declined from Dec. 2024 (kr11.01 Mil) to Jun. 2025 (kr9.64 Mil) but then stayed the same from Jun. 2025 (kr9.64 Mil) to Dec. 2025 (kr8.16 Mil).

Arctic Bioscience AS's annual Other Current Receivables declined from Dec. 2023 (kr11.15 Mil) to Dec. 2024 (kr11.01 Mil) and declined from Dec. 2024 (kr11.01 Mil) to Dec. 2025 (kr8.16 Mil).

Arctic Bioscience AS Other Current Receivables Related Terms

Arctic Bioscience AS Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Arctic Bioscience AS's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS Other Current Receivables Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 3.30 5.22 11.15 11.01 8.16

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.15 12.92 11.01 9.64 8.16
OSL:ABS
51GF Score
Arctic Bioscience AS OSL:ABS
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arctic Bioscience AS Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of kr8.16 Mil mean?
Arctic Bioscience AS (OSL:ABS) has a Other Current Receivables of kr8.16 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Arctic Bioscience AS and its competitors.
Is Arctic Bioscience AS's Other Current Receivables too high?
Arctic Bioscience AS's current Other Current Receivables is kr8.16 Mil. Overall, Arctic Bioscience AS has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's Other Current Receivables compare to VRTX and REGN?
Arctic Bioscience AS's Other Current Receivables of kr8.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Arctic Bioscience AS and its competitors. Arctic Bioscience AS's current Other Current Receivables is kr8.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Based on GuruFocus' analysis, Arctic Bioscience AS (OSL:ABS) is currently considered Possible Value Trap. The stock's GF Value™ is kr10.75, compared to a current price of kr2.80 — trading 74% below its estimated fair value. The current Other Current Receivables is kr8.16 Mil. Arctic Bioscience AS's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Arctic Bioscience AS (OSL:ABS), the current Other Current Receivables is kr8.16 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of kr2.80 is trading 74% below its estimated GF Value™ of kr10.75. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for OSL:ABS:

  • Other Current Receivables: kr8.16 Mil
  • GF Value™: kr10.75 vs. price of kr2.80 (74% below fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges 9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
51GF Score

Get the complete analysis for OSL:ABS

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.80
Price
kr10.75
GF Value